News & Articles

A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster

The partnership focuses on development, manufacturing and clinical adoption of neurodegenerative disease assays

New Aptiva® APS IgG and APS IgM reagents enable early diagnosis of Antiphospholipid Syndrome in hard-to-diagnose autoimmune disease

Through a combination of advanced imaging and novel artificial intelligence, latest diagnostic system for cervical cancer screening can help more accurately detect disease, improve workflow and enhance patient care

The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies

David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers

Sysmex Corporation announces that it has entered a strategic alliance agreement with CellaVision

The beta thalassemia test could help couples make informed reproductive choices, ensure appropriate maternal care, and facilitate diagnosis in infants

New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer

Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials

Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling

AI-based algorithm aims to enable cytotechnologists and pathologists to efficiently identify evidence of cervical cancer and precancerous lesions, using AI-based digital cervical system for pap testing.

Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy

In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy

HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high-throughput, high-quality analytical performance

The new assay allows for the quantitative measurement of Tau phosphorylated

With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance

Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)

Portable testing platforms are set to drive precision medicine and community health into 2024, so when will they see a more widespread adoption amongst healthcare providers and individuals alike?

Tell us which new products have had the biggest impact on your lab work for a chance to win a $500 Amazon.com Gift Card (or equivalent currency)

Learn how quantitative DBS technology could transform the clinical utility of dried blood spots and help drive the shift to self-sampling in healthcare

Discover how researchers at Weill Cornell Medical College are using immunoproteomics to identify biomarkers that help better understand and manage diabetic infections

Learn how researchers are using innovative gene editing techniques to uncover new drug targets

Could stronger collaboration from lab-to-frontline care be the key to advancing antimicrobial stewardship (AMS)?